Delusional Disorder: Clinical Trials

27 trials for Delusional Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 recruiting, 4 unknown, 2 terminated. 17 Not applicable, 4 Phase 4, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 10, Recruiting 3, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 44Completed 4
Phase 22Enrolling by invitation 1, Unknown 1
Phase 31Unknown 1

Follow Delusional Disorder: new trials by email Literature Review of Delusional Disorder trials Research Report on Delusional Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shared Decision Making for Antipsychotic Medications
The Antipsychotic Medication Decision Aid (APM-DA) - Schizophrenia, Schizoaffective Disorder
Not applicableNot yet recruitingNew York State Psychiatric Institute1202027-01-012026-03-30
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Collaborative Decision Skills Training, Leveling Up - Schizophrenia, Schizoaffective Disorder
Not applicableRecruitingVA Office of Research and Development1192026-08-122026-08-19
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
FEEL GOOD, Treatment as Usual (TAU) - Delusional Disorder, Brief Psychotic Disorder
Not applicableRecruitingStephanie Mehl2522026-05-272026-09-22
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities
SUCCEED Community-Based Intervention - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedLondon School of Hygiene and Tropical Medicine4252025-09-182026-06-08
Young Adults With Violent Behavior During Early Psychosis (Aim 2)
adapted behavioral intervention - Schizophrenia, Schizo Affective Disorder
Not applicableCompletedColumbia University122024-03-192026-10-05
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
Metacognitive Skills Training (MCT), Treatment as usual - Schizophrenia, Schizoaffective Disorder
Not applicableRecruitingUniversity of Jyvaskyla852023-09-012024-05-14
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia
RecruitingBeth Israel Deaconess Medical Center3202023-01-012026-03-10
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
Cognitive Remediation (REHACOP), Metacognitive Training (MCT) - Schizophrenia, Schizophreniform Disorders
Not applicableUnknownUniversitat Autonoma de Barcelona1602022-09-012024-05-23
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
Collaborative Decision Skills Training, Leveling Up - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedVA Office of Research and Development392022-07-052025-12-26
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
Rituximab - Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior
Phase 2Enrolling by invitationUppsala University Hospital402022-05-012024-11-19
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
Metacognitive and Defusion Training - Schizophrenia, Schizotypal Disorder
Not applicableCompletedMax-Planck-Institute of Psychiatry372021-05-102023-10-23
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis
OPUS YOUNG, Treatment as Usual - Schizophrenia, Schizotypal Disorder
Not applicableCompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2842021-05-062026-08-20
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders
Individual cognitive stimulation therapy (iCST) - Psychotic Disorders, Schizophrenia
Not applicableCompletedCEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas382021-03-292022-03-10
Research Into Antipsychotic Discontinuation and Reduction Trial
Antipsychotic Reduction, Antipsychotic Maintenance - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedUniversity College, London2532016-03-242022-05-23
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine, Placebo, Cognitive Behavioral Therapy - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedNYU Langone Health582014-02-012020-03-25
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
CBT-E, Treatment as Usual - Schizophrenia, Delusional Disorder
Not applicableCompletedPhilipps University Marburg642014-01-012020-03-04
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
agomelatine - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedCentral Institute of Mental Health, Mannheim272013-01-012018-03-08
Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Multi-element, team-oriented treatment - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedResearch Foundation for Mental Hygiene, Inc.652010-10-012016-11-03
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Risperidone/Olanzapine and PET scans - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedCentre for Addiction and Mental Health452009-10-012022-06-06
Acceptance and Commitment Therapy for Delusions
Acceptance and Commitment Therapy - Schizophrenia, Delusional Disorder
Not applicableCompletedWeill Medical College of Cornell University42008-04-012009-10-12

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Schizophrenia (27)  ·  Schizophrenia, Paranoid (27)  ·  Psychotic Disorders (25)  ·  Bipolar Disorder (4)  ·  Mental Disorders (4)  ·  Depressive Disorder, Major (3)  ·  Schizotypal Personality Disorder (3)  ·  Delusions (2)  ·  Emotional Regulation (2)  ·  Mania (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Aggression (1)  ·  Compulsive Behavior (1)  ·  Depression (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (25)  ·  Mental Disorders (23)  ·  Behavior (8)  ·  Behavioral Symptoms (4)  ·  Bipolar and Related Disorders (4)  ·  Mood Disorders (4)  ·  Social Behavior (4)  ·  Depressive Disorder (3)  ·  Personality Disorders (3)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Self-Control (2)  ·  Signs and Symptoms (2)

Interventions

Therapeutics (4)  ·  Cognitive Behavioral Therapy (2)  ·  Acceptance and Commitment Therapy (1)  ·  Benztropine (1)  ·  Cognitive Remediation (1)  ·  Cycloserine (1)  ·  Delivery of Health Care, Integrated (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Olanzapine (1)  ·  Risperidone (1)  ·  Rituximab (1)  ·  Sugars (1)  ·  agomelatine (1)  ·  ziprasidone (1)

Sponsors

Centre for Addiction and Mental Health (2)  ·  Philipps University Marburg (2)  ·  VA Office of Research and Development (2)  ·  AstraZeneca (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas (1)  ·  Central Institute of Mental Health, Mannheim (1)  ·  Columbia University (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Max-Planck-Institute of Psychiatry (1)  ·  Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (1)  ·  NYU Langone Health (1)  ·  New York State Psychiatric Institute (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)  ·  Research Foundation for Mental Hygiene, Inc. (1)

Countries

Germany (8)  ·  United States (8)  ·  Canada (2)  ·  Brazil (1)  ·  Denmark (1)  ·  Finland (1)  ·  Malawi (1)  ·  Nigeria (1)  ·  Portugal (1)  ·  Sierra Leone (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  Zimbabwe (1)

Top investigators

Emily Treichler, PhD (2)  ·  Ana Barajas Velez (1)  ·  Ana E Marques Castro, M.Sc. (1)  ·  Andreas Bechdolf, PD Dr. (1)  ·  Andreas Bechdolf, Prof. Dr. (1)  ·  Anne K Pagsberg, PhD (1)  ·  Ariel Graff, MD (1)  ·  Ariel Graff-Guerrero, MD,PhD (1)  ·  David C. Mamo, MD MSc (1)  ·  Donald C Goff, MD (1)  ·  Janessa O Carvalho, Ph.D. (1)  ·  Janet L Cunningham, MD PhD (1)  ·  Joanna Moncrieff, MBBS (1)

Results publications

PMID 24062154, PMID 24062155, PMID 25188752, PMID 27557949, PMID 28086010, PMID 28778554, PMID 29485988, PMID 31708810, PMID 31814102, PMID 32507378, PMID 33781352, PMID 36076205, PMID 37778356, PMID 38840160, PMID 41654084, PMID 42531158

NIH funding

2019 (1), K23MH126312 (1), R01MH127174 (1)